Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease.

Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, Ballabio A, Raben N. · 2013

Read Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. by Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, Ballabio A, Raben N. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3662313.txt.

Description

A master gene switch may clear the storage jams of a muscle disease, Spampanato and a large team report in a 2013 EMBO Molecular Medicine study. The disease is Pompe disease, where a missing enzyme lets sugar stores pile up in cell waste sacs. The switch, called TFEB in the text, can fire up cell self-eating and push waste sacs to empty at the cell surface.

Raising the switch in a new muscle cell system and in mouse models cut sugar load and sac size. It also sped the handling of self-eating sacs and cleared their build-up. The sacs pushed out bore marks of both waste and self-eating sacs. When self-eating was blocked by gene means, the switch lost nearly all effect. The authors name TFEB a sound target for a disease short on options.

Catalog record

CREATORSpampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, Ballabio A, Raben N.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3662313

Browse the full library · About the Tower of Babel